Precision BioSciences, Inc.
NASDAQ:DTIL
8.38 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.576 | 49.898 | 17.584 | 7.038 | 13.12 | 19.789 | 8.78 | 10.598 | 7.363 | 3.82 | 3.317 | 6.339 | 24.036 | 68.805 | 16.349 | 8.846 | 7.363 | 1.078 | 6.998 | 6.522 | 4.865 | 5.389 | 5.462 | 4.94 | 2.541 | 1.874 | 1.528 |
| Cost of Revenue
| 1.011 | 1.382 | 1.427 | 1.556 | 2.036 | 2.385 | 2.278 | 2.275 | 2.247 | 2.226 | 2.256 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.435 | 48.516 | 16.157 | 5.482 | 11.084 | 17.404 | 6.502 | 8.323 | 5.116 | 1.594 | 1.061 | 6.339 | 24.036 | 68.805 | 16.349 | 8.846 | 7.363 | 1.078 | 6.998 | 6.522 | 4.865 | 5.389 | 5.462 | 4.94 | 2.541 | 1.874 | 1.528 |
| Gross Profit Ratio
| -0.755 | 0.972 | 0.919 | 0.779 | 0.845 | 0.879 | 0.741 | 0.785 | 0.695 | 0.417 | 0.32 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 13.084 | 17.225 | 12.452 | 12.425 | 15.85 | 21.946 | 22.158 | 21.072 | 19.959 | 22.936 | 19.972 | 26.47 | 25.94 | 37.235 | 25.593 | 23.126 | 24.873 | 25.183 | 24.879 | 19.904 | 19.791 | 22.76 | 19.961 | 16.399 | 9.737 | 10.869 | 8.117 |
| General & Administrative Expenses
| 8.767 | 8.527 | 8.428 | 8.539 | 9.633 | 9.83 | 11.086 | 10.073 | 10.334 | 10.485 | 10.691 | 10.619 | 9.638 | 9.938 | 9.498 | 9.2 | 8.534 | 8.703 | 9.615 | 8.479 | 7.052 | 6.5 | 4.995 | 4.646 | 3.251 | 3.13 | 2.646 |
| Selling & Marketing Expenses
| 0 | 0 | -0.536 | -0.592 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 8.767 | 8.527 | 7.892 | 7.947 | 9.633 | 9.83 | 11.086 | 10.073 | 10.334 | 10.485 | 10.691 | 10.619 | 9.638 | 9.938 | 9.498 | 9.2 | 8.534 | 8.703 | 9.615 | 8.479 | 7.052 | 6.5 | 4.995 | 4.646 | 3.251 | 3.13 | 2.646 |
| Other Expenses
| 0 | 0 | 0 | -0.311 | 0.311 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.95 | -12.708 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 21.851 | 25.752 | 20.344 | 20.372 | 25.483 | 31.776 | 33.244 | 31.145 | 30.293 | 33.421 | 30.663 | 37.089 | 35.578 | 47.173 | 35.091 | 32.326 | 33.407 | 33.886 | 34.494 | 28.383 | 26.843 | 29.26 | 24.956 | 21.045 | 12.988 | 13.999 | 10.763 |
| Operating Income
| -16.425 | 24.146 | -4.187 | -14.89 | -12.363 | -11.987 | -24.464 | -20.547 | -22.93 | -29.601 | -27.346 | -30.75 | -11.542 | 21.632 | -18.742 | -23.48 | -26.044 | -32.808 | -27.496 | -21.861 | -21.978 | -23.871 | -19.494 | -16.105 | -10.447 | -12.125 | -9.235 |
| Operating Income Ratio
| -28.516 | 0.484 | -0.238 | -2.116 | -0.942 | -0.606 | -2.786 | -1.939 | -3.114 | -7.749 | -8.244 | -4.851 | -0.48 | 0.314 | -1.146 | -2.654 | -3.537 | -30.434 | -3.929 | -3.352 | -4.518 | -4.43 | -3.569 | -3.26 | -4.111 | -6.47 | -6.044 |
| Total Other Income Expenses Net
| 4.85 | 8.603 | 12.775 | 1.456 | -1.041 | -1.297 | -0.596 | -7.941 | -1.016 | -1.434 | -0.822 | 8.45 | 0.274 | 0.024 | 0.053 | 0.027 | 0.028 | 0.107 | 0.66 | 0.945 | 1.236 | 2.95 | -12.708 | 0.662 | 0.691 | 0.299 | 0.223 |
| Income Before Tax
| -16.425 | 32.749 | 8.588 | -13.434 | -12.11 | -11.891 | -25.06 | -28.488 | -23.946 | -31.035 | -28.168 | -22.29 | -11.279 | 21.656 | -18.689 | -23.453 | -26.016 | -32.701 | -26.836 | -20.916 | -20.742 | -19.436 | -31.783 | -15.443 | -9.756 | -11.826 | -9.012 |
| Income Before Tax Ratio
| -28.516 | 0.656 | 0.488 | -1.909 | -0.923 | -0.601 | -2.854 | -2.688 | -3.252 | -8.124 | -8.492 | -3.516 | -0.469 | 0.315 | -1.143 | -2.651 | -3.533 | -30.335 | -3.835 | -3.207 | -4.264 | -3.607 | -5.819 | -3.126 | -3.839 | -6.311 | -5.898 |
| Income Tax Expense
| 3.839 | -1.382 | 1.384 | 2.855 | -5.325 | -3.201 | -1.502 | 7.999 | 1.016 | 1.434 | 0.822 | 0.053 | 0.055 | 0.048 | 0 | 0.027 | 0.028 | 0.107 | 0.66 | 0.945 | 1.236 | 2.95 | -12.526 | -1.213 | 0.691 | 0.299 | 0.223 |
| Net Income
| -16.425 | 32.749 | 8.588 | -16.289 | -8.079 | -11.891 | -23.558 | -36.487 | -24.962 | -32.469 | -28.99 | -22.29 | -11.279 | 21.656 | -18.689 | -23.453 | -26.016 | -32.701 | -26.836 | -20.916 | -20.742 | -19.436 | -31.783 | -15.443 | -9.756 | -11.826 | -9.012 |
| Net Income Ratio
| -28.516 | 0.656 | 0.488 | -2.314 | -0.616 | -0.601 | -2.683 | -3.443 | -3.39 | -8.5 | -8.74 | -3.516 | -0.469 | 0.315 | -1.143 | -2.651 | -3.533 | -30.335 | -3.835 | -3.207 | -4.264 | -3.607 | -5.819 | -3.126 | -3.839 | -6.311 | -5.898 |
| EPS
| -2.25 | 4.7 | 1.7 | -4.06 | -2.1 | -3.13 | -6.35 | -9.87 | -6.76 | -14.33 | -14.25 | -10.98 | -5.67 | 11.25 | -9.9 | -13.4 | -14.95 | -18.9 | -15.69 | -12.3 | -12.27 | -11.64 | -19.24 | -13.77 | -8.7 | -10.54 | -8.03 |
| EPS Diluted
| -2.25 | 4.67 | 1.7 | -4.06 | -2.1 | -3.13 | -6.35 | -9.87 | -6.76 | -14.33 | -14.25 | -10.98 | -5.67 | 10.86 | -9.9 | -13.4 | -14.95 | -18.9 | -15.69 | -12.3 | -12.27 | -11.64 | -19.24 | -13.77 | -8.7 | -10.54 | -8.03 |
| EBITDA
| -16.425 | 24.146 | -2.76 | -13.334 | -11.532 | -11.41 | -23.762 | -16.006 | -21.294 | -28.631 | -25.87 | -28.009 | -8.925 | 24.344 | -16.276 | -20.982 | -23.517 | -30.248 | -24.446 | -19.107 | -19.341 | -18.268 | -30.662 | -16.519 | -9.171 | -11.314 | -8.554 |
| EBITDA Ratio
| -28.516 | 0.484 | -0.157 | -1.895 | -0.879 | -0.577 | -2.706 | -1.51 | -2.892 | -7.495 | -7.799 | -4.419 | -0.371 | 0.354 | -0.996 | -2.372 | -3.194 | -28.059 | -3.493 | -2.93 | -3.976 | -3.39 | -5.614 | -3.344 | -3.609 | -6.037 | -5.598 |